This Warning From the CEO of the World's Biggest Vaccine Maker Could Be Bad News for Novavax

Keith Speights, The Motley Fool
·4 min read
This Warning From the CEO of the World's Biggest Vaccine Maker Could Be Bad News for Novavax

Pretty much everything seems to be going as hoped for Novavax (NASDAQ: NVAX) these days. Novavax appears to be on track to win emergency use authorizations in the U.K., U.S., and other countries over the next few months. Adar Poonawalla, CEO of the Serum Institute of India (SII), the world's largest vaccine maker, issued a warning last week that could be bad news for Novavax.